{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T13:46:51Z","timestamp":1791121611293,"version":"4.1.0"},"reference-count":57,"publisher":"Public Library of Science (PLoS)","issue":"3","license":[{"start":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T00:00:00Z","timestamp":1299456000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0017462","type":"journal-article","created":{"date-parts":[[2011,3,7]],"date-time":"2011-03-07T16:58:31Z","timestamp":1299517111000},"page":"e17462","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":68,"title":["Placental Growth Factor Contributes to Micro-Vascular Abnormalization and Blood-Retinal Barrier Breakdown in Diabetic Retinopathy"],"prefix":"10.1371","volume":"6","author":[{"given":"Laura","family":"Kowalczuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elodie","family":"Touchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Omri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Jonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Valamanes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Berdugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Bigey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascale","family":"Massin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Jeanny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francine","family":"Behar-Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2011,3,7]]},"reference":[{"issue":"Pt 2","key":"ref1","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1038\/eye.1993.58","article-title":"Histopathology of diabetic retinopathy in man.","volume":"7","author":"A Garner","year":"1993","journal-title":"Eye (Lond)"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-2005-861361","article-title":"Pericytes and the pathogenesis of diabetic retinopathy.","volume":"37","author":"HP Hammes","year":"2005","journal-title":"Horm Metab Res"},{"issue":"22","key":"ref3","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1056\/NEJM199412013312203","article-title":"Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders.","volume":"331","author":"LP Aiello","year":"1994","journal-title":"N Engl J Med"},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S0002-9394(14)75794-0","article-title":"Increased vascular endothelial growth factor levels in the vitreous of eyes with proliferative diabetic retinopathy.","volume":"118","author":"AP Adamis","year":"1994","journal-title":"Am J Ophthalmol"},{"key":"ref5","first-page":"1241","article-title":"Section 5: Retinal Vascular Diseases. Chapter 66: Etiologic Mechanisms in Diabetic Retinopathy.","author":"RN Frank","year":"2005"},{"issue":"2","key":"ref6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1161\/01.CIR.0000080735.93327.00","article-title":"Cyclooxygenase-2 in human and experimental ischemic proliferative retinopathy.","volume":"108","author":"F Sennlaub","year":"2003","journal-title":"Circulation"},{"issue":"3","key":"ref7","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jcp.20525","article-title":"Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development.","volume":"206","author":"SA Vinores","year":"2006","journal-title":"J Cell Physiol"},{"issue":"7","key":"ref8","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1007\/s00125-006-0274-8","article-title":"Long-term global retinal microvascular changes in a transgenic vascular endothelial growth factor mouse model.","volume":"49","author":"WY Shen","year":"2006","journal-title":"Diabetologia"},{"issue":"3","key":"ref9","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1016\/S0002-9440(10)64063-1","article-title":"Intrachoroidal neovascularization in transgenic mice overexpressing vascular endothelial growth factor in the retinal pigment epithelium.","volume":"158","author":"C Schwesinger","year":"2001","journal-title":"Am J Pathol"},{"issue":"4","key":"ref10","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.2337\/diabetes.54.4.1141","article-title":"Non human Primate Models for Diabetic Ocular Neovascularization Using AAV2-Mediated Over-expression of Vascular Endothelial Growth Factor.","volume":"54","author":"C Lebherz","year":"2005","journal-title":"Diabetes"},{"issue":"3","key":"ref11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2337\/diabetes.52.3.857","article-title":"Enhanced recombinant adeno-associated virus-mediated vascular endothelial growth factor expression in the adult mouse retina: a potential model for diabetic retinopathy.","volume":"52","author":"PE Rakoczy","year":"2003","journal-title":"Diabetes"},{"issue":"4","key":"ref12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.preteyeres.2008.05.001","article-title":"Vascular endothelial growth factor in eye disease.","volume":"27","author":"JS Penn","year":"2008","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1136\/bjo.2007.127142","article-title":"Tractional retinal detachment following intravitreal bevacizumab (Avastin) in patients with severe proliferative diabetic retinopathy.","volume":"92","author":"JF Arevalo","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"ref14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.preteyeres.2008.09.002","article-title":"Vascular endothelial growth factor and diabetic complications.","volume":"27","author":"B Wirostko","year":"2008","journal-title":"Prog Retin Eye Res"},{"key":"ref15","first-page":"CD007419","article-title":"Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic.","volume":"4","author":"M Parravano","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2174\/157339906775473671","article-title":"Angiogenic and antiangiogenic factor in proliferative diabetic retinopathy.","volume":"1","author":"R Sim\u00f3","year":"2006","journal-title":"Curr Diabetes Rev"},{"key":"ref17","first-page":"109","article-title":"Increased expression of placenta growth factor in proliferative diabetic retinopathy.","volume":"78","author":"A Khaliq","year":"1998","journal-title":"Lab Invest"},{"issue":"12","key":"ref18","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.2337\/diacare.25.12.2352","article-title":"Vitreous levels of placenta growth factor and vascular endothelial growth factor in patients with proliferative diabetic retinopathy.","volume":"25","author":"Y Mitamura","year":"2002","journal-title":"Diabetes Care"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00125-006-0539-2","article-title":"Placental growth factor-1 and epithelial haemato-retinal barrier breakdown: potential implication in the pathogenesis of diabetic retinopathy.","volume":"50","author":"N Miyamoto","year":"2007","journal-title":"Diabetologia"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1076\/ceyr.18.6.490.5267","article-title":"Basement membrane and growth factor gene expression in normal and diabetic human retinas.","volume":"18","author":"KS Spirin","year":"1999","journal-title":"Curr Eye Res"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"9267","DOI":"10.1073\/pnas.88.20.9267","article-title":"Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.","volume":"15","author":"D Maglione","year":"1991","journal-title":"Proc Natl Acad Sci"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"25646","DOI":"10.1016\/S0021-9258(18)47298-5","article-title":"Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not Flk-1\/KDR.","volume":"269","author":"JE Park","year":"1994","journal-title":"J Biol Chem"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/nm884","article-title":"Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1.","volume":"9","author":"M Autiero","year":"2003","journal-title":"Nat Med"},{"key":"ref24","first-page":"517","article-title":"Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.","volume":"76","author":"M Ziche","year":"1997","journal-title":"Lab Invest"},{"issue":"8","key":"ref25","doi-asserted-by":"crossref","first-page":"3971","DOI":"10.1158\/0008-5472.CAN-04-3085","article-title":"Placenta growth factor over-expression inhibits tumor growth, angiogenesis, and metastasis by depleting vascular endothelial growth factor homodimers in orthotopic mouse models.","volume":"66","author":"L Xu","year":"2006","journal-title":"Cancer Res"},{"issue":"1","key":"ref26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S1535-6108(02)00028-4","article-title":"Placenta growth factor-1 antagonizes VEGF -induced angiogenesis and tumor growth by the formation of functionally active PlGF-1\/VEGF heterodimers.","volume":"1","author":"A Eriksson","year":"2002","journal-title":"Cancer Cell"},{"issue":"6","key":"ref27","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1074\/jbc.271.6.3154","article-title":"Heterodimers of placenta growth factor\/vascular endothelial growth factor. Endothelial activity, tumor cell expression, and high affinity binding to Flk-1\/KDR.","volume":"271","author":"Y Cao","year":"1996","journal-title":"J Biol Chem"},{"issue":"49","key":"ref28","doi-asserted-by":"crossref","first-page":"35172","DOI":"10.1074\/jbc.274.49.35172","article-title":"Placenta growth factor and vascular endothelial growth factor B and C expression in microvascular endothelial cells and pericytes. Implication in autocrine and paracrine regulation of angiogenesis.","volume":"274","author":"H Yonekura","year":"1999","journal-title":"J Biol Chem"},{"issue":"3","key":"ref29","first-page":"577","article-title":"Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor.","volume":"13","author":"G Viglietto","year":"1996","journal-title":"Oncogene"},{"issue":"6","key":"ref30","first-page":"2696","article-title":"Placenta growth factor gene expression is induced by hypoxia in fibroblasts: a central role for metal transcription factor-1.","volume":"61","author":"CJ Green","year":"2001","journal-title":"Cancer Res"},{"issue":"2","key":"ref31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.healun.2008.11.917","article-title":"Hypoxia increases placenta growth factor expression in human myocardium and cultured neonatal rat cardiomyocytes.","volume":"28","author":"RJ Torry","year":"2009","journal-title":"J Heart Lung Transplant"},{"issue":"12","key":"ref32","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1038\/nrc2524","article-title":"Flt-1 and its ligands VEGFB and PlGF: drug targets for anti-angiogenic therapy.","volume":"8","author":"C Fischer","year":"2008","journal-title":"Nat Rev Cancer"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/87904","article-title":"Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions.","volume":"7","author":"P Carmeliet","year":"2001","journal-title":"Nat Med"},{"issue":"7","key":"ref34","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1096\/fj.05-4481fje","article-title":"Plgf-\/-eNos-\/- mice show defective angiogenesis associated with increased oxidative stress in response to tissue ischemia.","volume":"20","author":"B Gigante","year":"2006","journal-title":"Faseb J"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1242\/jcs.115.12.2559","article-title":"Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability.","volume":"115","author":"T Odorisio","year":"2002","journal-title":"J Cell Sci"},{"issue":"2","key":"ref36","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1167\/iovs.02-0040","article-title":"Role of vascular endothelial growth factor and placental growth factors during retinal vascular development and hyaloid regression.","volume":"44","author":"SA Feeney","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1167\/iovs.02-1092","article-title":"Placenta growth factor, a member of the VEGF Family, contribute to the development of choroidal neovascularization.","volume":"44","author":"JM Rakic","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"6","key":"ref38","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/sj.gt.3302653","article-title":"Potential applications for RNAi to probe pathogenesis and develop new treatments for ocular disorders.","volume":"13","author":"PA Campochiaro","year":"2006","journal-title":"Gene Ther"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI17808","article-title":"Selective stimulation of VEGFR-1 prevents oxygen-induced retinal vascular degeneration in retinopathy of prematurity.","volume":"112","author":"SC Shih","year":"2003","journal-title":"J Clin Invest"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1096\/fj.05-4737fje","article-title":"Plasmid ET of eye ciliary muscle: principles and therapeutic efficacy using hTNF-alpha soluble receptor in uveitis.","volume":"20","author":"C Bloquel","year":"2006","journal-title":"Faseb J"},{"issue":"7","key":"ref41","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1038\/gt.2009.43","article-title":"Effects of ciliary muscle plasmid electrotransfer of TNF-alpha soluble receptor variants in experimental uveitis.","volume":"16","author":"E Touchard","year":"2009","journal-title":"Gene Ther"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1167\/iovs.08-3027","article-title":"Local ocular immunomodulation results from electrotransfer of plasmid encoding soluble TNF receptors in the ciliary muscle.","volume":"50","author":"L Kowalczuk","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"ref43","article-title":"The ciliary smooth muscle electrotransfer: Basic principles and potential for sustained intraocular production of therapeutic proteins.","author":"E Touchard","year":"2010","journal-title":"J Gene Med. on line"},{"issue":"6","key":"ref44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.preteyeres.2010.04.001","article-title":"Protein delivery for retinal diseases: From basic considerations to clinical applications.","volume":"29","author":"M* El Sanharawi","year":"2010","journal-title":"Prog Retin Eye Res"},{"issue":"8-9","key":"ref45","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1016\/j.visres.2005.09.037","article-title":"High resolution fundus imaging by confocal scanning laser ophthalmoscopy in the mouse.","volume":"46","author":"M Paques","year":"2006","journal-title":"Vision Res"},{"issue":"7","key":"ref46","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00417-009-1082-x","article-title":"Involvement of M\u00fcller glial cells in epiretinal membrane formation.","volume":"247","author":"A Bringmann","year":"2009","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"ref47","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.cell.2010.02.039","article-title":"Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease.","volume":"141","author":"S Van de Veire","year":"2010","journal-title":"Cell"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","first-page":"e3554","DOI":"10.1371\/journal.pone.0003554","article-title":"Endogenous VEGF is required for visual function: evidence for a survival role on m\u00fcller cells and photoreceptors.","volume":"3","author":"M Saint-Geniez","year":"2009","journal-title":"PLoS One"},{"issue":"2","key":"ref49","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1073\/pnas.0911661107","article-title":"VEGFR1-mediated pericyte ablation links VEGF and PlGF to cancer-associated retinopathy.","volume":"107","author":"R Cao","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"4","key":"ref50","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2002-11-3423","article-title":"Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor.","volume":"102","author":"SK Selvaraj","year":"2003","journal-title":"Blood"},{"issue":"2","key":"ref51","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/art.24289","article-title":"Role of placenta growth factor and its receptor flt-1 in rheumatoid inflammation: a link between angiogenesis and inflammation.","volume":"60","author":"SA Yoo","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"6","key":"ref52","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1189\/jlb.0307164","article-title":"Placental growth factor down-regulates type 1 T helper immune response by modulating the function of dendritic cells.","volume":"82","author":"YL Lin","year":"2007","journal-title":"J Leukoc Biol"},{"issue":"3","key":"ref53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.cell.2007.08.038","article-title":"Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels.","volume":"131","author":"C Fischer","year":"2007","journal-title":"Cell"},{"issue":"1","key":"ref54","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ophtha.2008.09.036","article-title":"Effect of intravitreal bevacizumab injection on aqueous humor cytokine levels in clinically significant macular edema.","volume":"116","author":"MI Roh","year":"2009","journal-title":"Ophthalmology"},{"key":"ref55","article-title":"VEGF Trap-Eye Shows Positive Results in a Phase 2 Study in Patients With Diabetic Macular Edema (news-releases February, 20 2010)","year":"2010"},{"issue":"37","key":"ref56","doi-asserted-by":"crossref","first-page":"25404","DOI":"10.1074\/jbc.M804349200","article-title":"Activation of the VEGFR1 chromatin domain: an angiogenic signal-ETS1\/HIF-2alpha regulatory axis.","volume":"283","author":"D Dutta","year":"2008","journal-title":"J Biol Chem"},{"issue":"8","key":"ref57","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1109\/TPAMI.2004.44","article-title":"Design of Steerable Filters for Feature Detection Using Canny-Like Criteria.","volume":"26","author":"M Jacob","year":"2004","journal-title":"IEEE Transactions on Pattern Analysis and Machine Intelligence"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0017462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,19]],"date-time":"2021-11-19T21:20:21Z","timestamp":1637356821000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0017462"}},"subtitle":[],"editor":[{"given":"Christian","family":"Schulz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2011,3,7]]},"references-count":57,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2011,3,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0017462","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,7]]}}}